Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.
about
In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasisDiverse nitrogen sources in seminal fluid act in synergy to induce filamentous growth of Candida albicans.Extracellular enzymes and susceptibility to fluconazole in Candida strains isolated from patients with vaginitis and healthy individuals.In Vitro Activity of Tea Tree Oil Vaginal Suppositories against Candida spp. and Probiotic Vaginal Microbiota.A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.Mechanistic Insights Underlying Tolerance to Acetic Acid Stress in Vaginal Candida glabrata Clinical Isolates.Medically important fungi respond to azole drugs: an update.Chemical and physical strategies in onychomycosis topical treatment: A review.Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.[Candiduria! What now? : Therapy of urinary tract infections with Candida].Stratum corneum lipid liposome-encapsulated panomycocin: preparation, characterization, and the determination of antimycotic efficacy against Candida spp. isolated from patients with vulvovaginitis in an in vitro human vaginal epithelium tissue modepH-Dependant Antifungal Activity of Valproic Acid against the Human Fungal Pathogen Candida albicans.In vitro human onychopharmacokinetic and pharmacodynamic analyses of ME1111, a new topical agent for onychomycosis.Candida vaginitis during contraceptive use: the influence of methods, antifungal susceptibility and virulence patterns.Pulsed electric field-assisted sensitization of multidrug-resistant Candida albicans to antifungal drugs.Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant Candida albicans and Non-albicans Candida Species.
P2860
Q33589734-E9C07998-9080-40F0-8321-C44D67670F13Q35221101-F84CF868-49AD-420A-870D-873D7C3A49EAQ35276239-0A257673-ABC6-427C-BEB8-35F45F32A2A6Q35734134-9E8D7A31-479A-443F-8342-6AF8DAC600E6Q37287736-5CA33DFA-3A1A-4A3A-83D4-37EFB3BA9C42Q37670507-50598E57-F71E-4F8F-992B-A17972B440B0Q38559208-F9A4F871-B113-45BA-A171-975CA18EFCCAQ38972262-DEDFC744-DECB-4D10-B131-721A931EC631Q40175191-1DDBE365-203C-4008-B9C9-51027A59AF86Q40553043-C9748549-8A96-413D-873F-70D62DF302E1Q41301876-0D8AB465-B39D-4DAC-99AD-C9533538F0E3Q43191770-18090722-D129-4A07-A5A9-28DCED0D2715Q46155648-DCB57876-2606-4A04-8F95-FF252F1E21C4Q46972633-AD0BE475-B58F-474F-ABAD-A434F76416C8Q47789181-D8825CD4-B6EA-4E9F-8E2D-1C1EEB30BF1CQ53692883-92229920-28F8-4BFA-B54C-8FED63032E32
P2860
Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effect of pH on in vitro susce ...... implications for clinical use.
@ast
Effect of pH on in vitro susce ...... implications for clinical use.
@en
type
label
Effect of pH on in vitro susce ...... implications for clinical use.
@ast
Effect of pH on in vitro susce ...... implications for clinical use.
@en
prefLabel
Effect of pH on in vitro susce ...... implications for clinical use.
@ast
Effect of pH on in vitro susce ...... implications for clinical use.
@en
P2093
P2860
P356
P1476
Effect of pH on in vitro susce ...... implications for clinical use.
@en
P2093
Claire S Danby
Dina Boikov
Jack D Sobel
Rina Rautemaa-Richardson
P2860
P304
P356
10.1128/AAC.05025-11
P407
P577
2012-01-09T00:00:00Z